Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0039483 (
giant cell arteritis
)
3,204
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Analysis of
TBP
gene sequences from a variety of species for clustering of short sequence motifs and for over- and underrepresentation of short sequence motifs suggests involvement of slippage in the recent evolution of the
TBP
N-terminal domains in metazoans, Acanthamoeba and wheat. AGC,
GCA
and CAG are overrepresented in
TBP
genes of other species, suggesting that opa arrays were amplified from motifs overrepresented in ancestral species. The phylogenetic distribution of recently slippage-derived sequences in
TBP
is similar to that observed in the large subunit ribosomal RNAs, suggesting a propensity for certain evolutionary lineages to incorporate slippage-generated motifs into protein-coding as well as ribosomal RNA genes. Because length increase appears to have taken place independently in lineages leading to vertebrates, insects and nematodes,
TBP
N-terminal domains in these lineages are not homologous. All gene duplications in the
TBP
gene family appear to have been recent events despite strong protein sequence similarity between TRF and P. falciparum
TBP
. The enlargement of the
TBP
N-terminal domain may have coincided with acquisition of new functions and may have accompanied molecular coevolution with domains of other proteins, resulting in the acquisition of new or more complex mechanisms of transcription regulation.
...
PMID:Evolution of sequence repetition and gene duplications in the TATA-binding protein TBP (TFIID). 833 91